Word

IMMIPRINT

Status

Registered

Status Code

414

Status Date

Tuesday, June 4, 2019

Serial Number

79219912

Registration Number

5766272

Registration Date

Tuesday, June 4, 2019

Mark Type

4000

Filing Date

Wednesday, September 6, 2017

Published for Opposition

Tuesday, March 19, 2019

Trademark Owner History

ProteinLogic Limited - Original Registrant

Classifications

9 Laboratory apparatus and equipment for use in the detection of soluble Cluster of Differentiation (CD) antigens, soluble immune system proteins, other soluble proteins in bodily fluids, and other soluble proteins in bodily fluids, namely, cytokines, all for research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases, namely, microplate readers, antibody bio-chips, flow cytometers, immuno detectors, microfluidic bio-chips, photometers, piezo electrical transducers, acoustic detectors and mass spectrometers; scientific apparatus and equipment for research purposes for use in the detection of soluble CD antigens, soluble immune system proteins, other soluble proteins in bodily fluids, and other soluble proteins in bodily fluids, namely, cytokines, all for use in the research of human and animal diseases and for the research of treatments and therapies for human and animal diseases, namely, microplate readers, antibody bio-chips, flow cytometers, immuno detectors, microfluidic bio-chips, photometers, piezo electrical transducers, acoustic detectors and mass spectrometers; measuring apparatus and instruments for use in connection with the research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases; computer software for receiving, processing, collating, analysing, transmitting, displaying and storing information and data, in connection with the research and diagnosis of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases; machine readable data carriers for use in connection with the research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases; data storage media for use with computers, namely, high speed computer storage sub-systems for storage and backup of electronic data either locally or via a telecommunications network, for receiving, processing, collating, analysing, transmitting, displaying and storing information and data, in connection with the research, diagnosis and monitoring of human and animal diseases and for the research and monitoring of treatments and therapies for human and animal diseases

10 Apparatus for clinical, medical and veterinary diagnosis, namely, reagent panels, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic biochips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing; medical and veterinary testing apparatus for diagnosing human and animal diseases, in particular ones containing chemical and/or biochemical reagents, namely, reagent panels, microplate readers for blood and body fluid based diagnostic testing, antibody bio-chips for blood and body fluid based diagnostic testing, flow cytometers for blood and body fluid based diagnostic testing, immuno detectors for blood and body fluid based diagnostic testing, microfluidic bio-chips for blood and body fluid based diagnostic testing, photometers for blood and body fluid based diagnostic testing, piezo electrical transducers for blood and body fluid based diagnostic testing, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing; apparatus and instruments for medical and clinical analysis diagnosis for use in the detection of soluble CD antigens, soluble immune system proteins, other soluble proteins in bodily fluids, and other soluble proteins in bodily fluids, namely, cytokines, all for use in the diagnosis and monitoring of human and animal diseases and for the monitoring of treatments and therapies for human and animal diseases, namely, reagent panels, microplate readers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, antibody biochips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, flow cytometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring or predicting response to treatments or therapies, and patient stratification, immuno detectors for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, microfluidic bio-chips for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, photometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, piezo electrical transducers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification, acoustic detectors and mass spectrometers for blood and body fluid based diagnostic testing of one or more disease states in an individual, and monitoring and predicting response to treatments and therapies, and patient stratification

42 Scientific research; bacteriological research; biochemical research and development; biological research; clinical research in the nature of providing medical and scientific research information in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics; medical research, biomedical research services; chemical research and analysis services in the nature of providing medical and scientific research information in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics; genetic research in the nature of providing medical and scientific research information in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics; design services in the field of biomarker signature discovery and immune system response based diagnostics and proteomic diagnostics

Trademark Events

Dec 29, 2022

Limitation From The Ib Examined And Entered

Dec 29, 2022

Notification Of Effect Of Cancellation Of Intl Reg E-Mailed

Sep 10, 2022

Limitation Of Goods Received From Ib

Oct 4, 2019

Final Decision Transaction Processed By Ib

Sep 18, 2019

Final Disposition Notice Sent To Ib

Sep 18, 2019

Final Disposition Processed

Sep 4, 2019

Final Disposition Notice Created, To Be Sent To Ib

Jun 4, 2019

Registered-Principal Register

Apr 19, 2019

Notification Of Possible Opposition - Processed By Ib

Apr 3, 2019

Notification Of Possible Opposition Sent To Ib

Apr 3, 2019

Notification Of Possible Opposition Created, To Be Sent To Ib

Mar 19, 2019

Official Gazette Publication Confirmation E-Mailed

Mar 19, 2019

Published For Opposition

Mar 15, 2019

Notification Processed By Ib

Feb 27, 2019

Notification Of Possible Opposition Sent To Ib

Feb 27, 2019

Notification Of Notice Of Publication E-Mailed

Feb 27, 2019

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Feb 14, 2019

Law Office Publication Review Completed

Feb 13, 2019

Exparte Appeal Terminated

Feb 13, 2019

Approved For Pub - Principal Register

Feb 13, 2019

Examiner's Amendment Entered

Feb 13, 2019

Notification Of Examiners Amendment E-Mailed

Feb 13, 2019

Examiners Amendment E-Mailed

Feb 13, 2019

Examiners Amendment -Written

Feb 1, 2019

Teas/Email Correspondence Entered

Feb 1, 2019

Correspondence Received In Law Office

Jan 29, 2019

Assigned To Lie

Jan 24, 2019

Teas Request For Reconsideration Received

Jan 24, 2019

Ex Parte Appeal-Instituted

Jan 24, 2019

Jurisdiction Restored To Examining Attorney

Jan 24, 2019

Exparte Appeal Received At Ttab

Jul 24, 2018

Final Refusal Mailed

Jul 24, 2018

Final Refusal Written

Jun 27, 2018

Teas/Email Correspondence Entered

Jun 27, 2018

Correspondence Received In Law Office

Jun 27, 2018

Teas Response To Office Action Received

Jan 19, 2018

Refusal Processed By Ib

Dec 28, 2017

Non-Final Action Mailed - Refusal Sent To Ib

Dec 28, 2017

Refusal Processed By Mpu

Dec 14, 2017

Non-Final Action (Ib Refusal) Prepared For Review

Dec 13, 2017

Non-Final Action Written

Dec 11, 2017

Assigned To Examiner

Nov 10, 2017

Application Filing Receipt Mailed

Nov 6, 2017

New Application Office Supplied Data Entered In Tram

Nov 2, 2017

Sn Assigned For Sect 66a Appl From Ib